眼科レーザーの世界市場予測（～2021年）：フェムト秒レーザー、エキシマレーザー、Nd:YAGレーザー、ダイオードレーザー...市場調査レポートについてご紹介

1 Introduction (Page No. – 14)
1.1 Objectives of Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 17)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 28)
3.1 Introduction
3.2 Conclusion

4 Premium Insights (Page No. – 33)
4.1 Global Market Overview
4.2 Geographic Analysis: Market, By Product
4.3 Geographic Snapshot: Market
4.4 Global Market, By Application (2016 vs 2021)
4.5 Global Market, By End User (2016 vs 2021)

5 Market Overview (Page No. – 38)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Prevalence of Ophthalmic Disorders
5.2.1.2 Rapid Growth in Geriatric Population
5.2.1.3 Technological Advancements and Increasing Regulatory Approvals for Ophthalmic Lasers
5.2.1.4 Rising Prevalence of Chronic Diseases Such as Diabetes
5.2.1.5 Increasing Initiatives to Control Visual Impairment
5.2.2 Restraint
5.2.2.1 High Cost of Equipment and Therapy
5.2.3 Opportunity
5.2.3.1 Growth Potential Offered By Emerging Economies
5.2.4 Threats
5.2.4.1 Availability of Alternative Therapies
5.2.5 Challenge
5.2.5.1 Unfavorable Reimbursements for Laser Eye Surgeries

6 Ophthalmic Lasers Market, By Product (Page No. – 44)
6.1 Introduction
6.2 Femtosecond Lasers
6.3 Excimer Lasers
6.4 ND:Yag Lasers
6.5 Diode Lasers
6.6 Others

7 Ophthalmic Lasers Market, By Application (Page No. – 52)
7.1 Introduction
7.2 Refractive Error Correction
7.3 Cataract Removal
7.4 Diabetic Retinopathy Treatment
7.5 Glaucoma Treatment
7.6 Age-Related Macular Degeneration Treatment
7.7 Others

8 Ophthalmic Lasers Market, By End User (Page No. – 61)
8.1 Introduction
8.2 Hospitals
8.3 Specialty Clinics and Ambulatory Surgery Centers

9 Ophthalmic Lasers Market, By Region (Page No. – 65)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.1.1 Rising Prevalence of Ophthalmic Disorders in the U.S.
9.2.1.2 Rising Prevalence of Chronic Diseases
9.2.1.3 Increasing Regulatory Approvals in the U.S.
9.2.2 Canada
9.2.2.1 Growing Burden of Ophthalmic Disorders in Canada
9.3 Europe
9.3.1 Germany
9.3.1.1 Increasing Incidence of Severe Blindness and Visual Impairment
9.3.1.2 Increasing Awareness on Laser Therapy
9.3.2 France
9.3.2.1 Medical Tourism in France
9.3.3 Spain
9.3.3.1 Favorable Outlook for Market Growth
9.3.4 Rest of Europe (RoE)
9.3.4.1 Rising Aging Population
9.3.4.2 U.K.: Increasing Burden of Vision Impairment
9.3.4.3 Conferences and Symposiums
9.4 Asia-Pacific
9.4.1 China
9.4.1.1 High Prevalence of Target Diseases
9.4.1.2 Introduction of Blindness Prevention and Treatment Projects
9.4.2 India
9.4.2.1 Increasing Prevalence of Target Conditions in India
9.4.2.2 Rising Aging Population
9.4.3 Japan
9.4.3.1 Increasing Aging Population in Japan
9.4.4 Rest of Asia-Pacific (RoAPAC)
9.4.4.1 Rapid Increase in Refractive Surgeries in South Korea
9.4.4.2 Increasing Prevalence of Visual Impairment and Increasing Government Initiatives to Reduce the Disease Burden in Australia
9.4.4.3 Increasing Prevalence of Vision Impairment in Asia
9.5 Rest of the World
9.5.1 Rising Aging Population & Prevalence of Diabetes

10 Competitive Landscape (Page No. – 106)
10.1 Overview
10.2 Market Share Analysis
10.2.1 Introduction
10.2.2 Alcon Laboratories, Inc.
10.2.3 Abbott Medical Optics, Inc.
10.2.4 Carl Zeiss Meditec AG
10.2.5 Bausch & Lomb Incorporated
10.3 Competitive Situation and Trends
10.3.1 Product Approvals
10.3.2 New Product Launches
10.3.3 Agreements, Alliances, Partnerships, and Collaborations
10.3.4 Acquisitions
10.3.5 Expansions
10.3.6 Others

11 Company Profiles (Page No. – 116)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Introduction
11.2 Alcon Laboratories, Inc. (A Novartis AG Company)
11.3 Abbott Medical Optics, Inc. (A Subsidiary of Abbott)
11.4 Carl Zeiss Meditec AG
11.5 Bausch & Lomb Incorporated (A Valeant Pharmaceuticals International, Inc. Company)
11.6 Ellex Medical Lasers Limited
11.7 Topcon Corporation
11.8 Ziemer Ophthalmic Systems AG (A Subsidiary of Ziemer Group Holding AG)
11.9 Iridex Corporation
11.10 Nidek Co., Limited
11.11 Lumenis Ltd. (A XIO Group Company)

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 138)
12.1 Discussion Guide
12.2 Company Developments
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports